These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 696380)

  • 1. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
    Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
    Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness.
    Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA
    Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078
    [No Abstract]   [Full Text] [Related]  

  • 3. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 4. Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
    Vestergaard P; Yates CM
    Clin Chim Acta; 1978 Jul; 87(2):297-9. PubMed ID: 148982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 7. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
    Ricaurte GA; Finnegan KT; Irwin I; Langston JW
    Ann N Y Acad Sci; 1990; 600():699-708; discussion 708-10. PubMed ID: 1701292
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.
    Banki CM
    Eur J Clin Pharmacol; 1977 Apr; 11(4):311-5. PubMed ID: 862653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism.
    Granerus AK; Magnusson T; Roos BE; Svanborg A
    Eur J Clin Pharmacol; 1974; 7(2):105-9. PubMed ID: 4854088
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid measurements suggest precursor availability and sex are involved in the control of biogenic amine metabolism in a primate.
    Young SN; Ervin FR
    J Neurochem; 1984 Jun; 42(6):1570-3. PubMed ID: 6202838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder.
    Lepola U; Jolkkonen J; Pitkänen A; Riekkinen P; Rimón R
    Ann Med; 1990; 22(4):237-9. PubMed ID: 1701091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central noradrenergic function in man: vanillylmandelic acid in CSF.
    Jimerson DC; Gordon EK; Post RM; Goodwin FK
    Brain Res; 1975 Dec; 99(2):434-9. PubMed ID: 1182564
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 16. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients.
    Mendels J; Frazer A; Fitzgerald RG; Ramsey TA; Stokes JW
    Science; 1972 Mar; 175(4028):1380-2. PubMed ID: 5059569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified amine hypothesis for the aetiology of affective illness.
    Lancet; 1972 Sep; 2(7777):573-7. PubMed ID: 4115743
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of ECT on sleep and CSF biogenic amines in affective illness.
    Hoffmann G; Linkowski P; Kerkhofs M; Desmedt D; Mendlewicz J
    Psychiatry Res; 1985 Nov; 16(3):199-206. PubMed ID: 2418453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on cerebrospinal fluid levels of metabolites of biopterin and biogenic amines.
    Komori H; Matsuishi T; Yamada S; Ueda N; Yamashita Y; Kato H
    Acta Paediatr; 1999 Dec; 88(12):1344-7. PubMed ID: 10626519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites.
    Gold PW; Goodwin FK; Wehr T; Rebar R
    Am J Psychiatry; 1977 Sep; 134(9):1028-31. PubMed ID: 409301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.